News Focus
News Focus
Post# of 257566
Next 10
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 143305

Tuesday, 06/05/2012 7:27:49 PM

Tuesday, June 05, 2012 7:27:49 PM

Post# of 257566
Tough day for ThromboGenics and BioInvent—in addition to the failure and program termination of TB-402 (#msg-76294033), former partner Roche dumped TB-403, a cancer drug targeting PIGF:

http://finance.yahoo.com/news/thrombogenics-bioinvent-regain-full-rights-053200538.html

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today